India's Richest People 2026 edition · Source: Hurun India
Rank#389- Wealth
- ₹9,600 Cr
- Company
- Aurobindo Pharma
2019 #484 2018 #451 2017 #182
Current companies 12 active board seats
Past companies 11 historical roles
Total affiliations 23 Since Dec 1992
Shareholding value •••• Premium profile
About Nityananda Reddy Kambam
Data last updated:
Nityananda Reddy Kambam is a Managing Director at Aurobindo Pharma Ltd (since 1992), Director at Apitoria Pharma Private Limited (since 2023) and Director at Apl Healthcare Limited (since 2006), and holds 9 more current directorships. The companies operate in Pharma, Chemicals and Materials and Real Estate and Construction. The 8 current companies with reported revenue have a combined latest revenue of ₹45,630 Cr; the largest is Aurobindo Pharma Ltd at ₹34,145 Cr (FY 2026). Earlier, Nityananda Reddy Kambam was an Additional Director at Curateq Biologics Private Limited (2020) and Director at Auro Peptides Limited (2012–2021) and 9 more.
Nityananda Reddy and family are #389 among India's richest people (2026), with wealth of ₹9,600 Cr.
DIN 01284195
Primary Designation Managing Director
Industry Pharma
First Appointment 30 Dec 1992
Oldest Company Age 39 yrs
Largest company Aurobindo Pharma Ltd · ₹34,145 Cr (FY 2026)
Combined revenue ₹45,630 Cr across 8 companies
Recognitions & Rankings
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aurobindo Pharma Ltd L24239TG1986PLC015190 | Managing Director | 30 Dec 1992 | 1986 | ₹34,145 Cr (FY 2026) | Active |
| Apitoria Pharma Private Limited U24298TG2017PTC121342 | Director | 09 Feb 2023 | 2017 | ₹6,812 Cr (FY 2025) | Active |
| Apl Healthcare Limited U24239TG2006PLC052053 | Director | 19 Dec 2006 | 2006 | ₹4,413 Cr (FY 2025) | Active |
| Raidurgam Developers Limited U45100TG2012PLC081892 | Director | 10 Jul 2012 | 2012 | ₹190 Cr (FY 2025) | Active |
| Aurobindo Pharma Foundation U85200TG2020NPL141954 | Director | 20 Jul 2020 | 2020 | ₹50.45 Cr (FY 2025) | Active |
 Pattancheru Enviro-Tech Limited U29219TG1989PLC009683 | Director | 26 Sep 2001 | 1989 | ₹19.79 Cr (FY 2025) | Active |
| Lyfius Pharma Private Limited U24299AP2020PTC116443 | Director | 01 Dec 2023 | 2020 | ₹2 Lakh (FY 2023) | Active |
| Qule Pharma Private Limited U24304AP2020PTC116442 | Director | 01 Dec 2023 | 2020 | ₹50,000 (FY 2023) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Curateq Biologics Private Limited U24110TG2020PTC140190 | Additional Director | 02 May 2020 | 2020 | ₹9.49 Cr (FY 2025) | Active |
| Auro Peptides Limited U24232TG2012PLC078350 | Director | 02 Jan 2012 | 2012 | ₹23.52 Cr (FY 2025) | Active |
| Curepro Parenterals Limited U24232TG2013PLC087101 | Director | 19 Apr 2013 | 2013 | Amalgamated | |
 Pharmaceuticals Export Promotion Council Of India U24239TG2004NPL043058 | Director | 13 Apr 2004 | 2004 | ₹35.95 Cr (FY 2024) | Active |
| Auronext Pharma Private Limited U74999TG2009PTC109591 | Director | 30 Jul 2010 | 2009 | ₹75.8 Lakh (FY 2023) | Amalgamated |
| Senor Organics Pvt Ltd U24110TG1993PTC016703 | Director | 30 Nov 2006 | 1993 | Amalgamated | |
| Apl Research Centre Limited U24116TG2006PLC051171 | Director | 15 Sep 2006 | 2006 | Amalgamated | |
| Hyacinths Pharma Private Limited U24232TG2010PTC069638 | Director | 16 Sep 2013 | 2010 | Amalgamated | |
| Aurozymes Limited U24232TG2013PLC091383 | Director | 28 Nov 2013 | 2013 | Amalgamated | |
 Trident Life Sciences Limited U24239TG2004PLC044102 | Additional Director | 18 Sep 2009 | 2004 | Amalgamated | |
 Silicon Life Sciences Private Limited U85100TG2008PTC057669 | Director | 30 Aug 2013 | 2008 | ₹139 Cr (FY 2020) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nityananda Reddy Kambam
Directorship timeline
Open interactive timeline →Aurobindo Pharma Ltd
Engenra Biologics Private Limited
Avogent Lifesciences Private Limited
Aurobindo Antibiotics Private Limited
Premium access
Shareholding and investment profile for Nityananda Reddy Kambam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nityananda Reddy Kambam
Nityananda Reddy Kambam currently holds 12 directorships: Aurobindo Pharma Ltd (Managing Director, since 30 Dec 1992, revenue ₹34,145 Cr (FY 2026)); Apitoria Pharma Private Limited (Director, since 09 Feb 2023, revenue ₹6,812 Cr (FY 2025)); Apl Healthcare Limited (Director, since 19 Dec 2006, revenue ₹4,413 Cr (FY 2025)); Raidurgam Developers Limited (Director, since 10 Jul 2012, revenue ₹190 Cr (FY 2025)); Aurobindo Pharma Foundation (Director, since 20 Jul 2020, revenue ₹50.45 Cr (FY 2025)); and 7 more.
Nityananda Reddy Kambam was first appointed on 30 Dec 1992 as Managing Director at Aurobindo Pharma Ltd. The most recent appointment on record is 31 Aug 2026 at Avogent Lifesciences Private Limited.
The 8 current companies of Nityananda Reddy Kambam that report revenue have a combined latest revenue of ₹45,630 Cr: Aurobindo Pharma Ltd ₹34,145 Cr (FY 2026); Apitoria Pharma Private Limited ₹6,812 Cr (FY 2025); Apl Healthcare Limited ₹4,413 Cr (FY 2025); Raidurgam Developers Limited ₹190 Cr (FY 2025); Aurobindo Pharma Foundation ₹50.45 Cr (FY 2025); and 3 more.
Nityananda Reddy Kambam held 11 earlier board appointments: Curateq Biologics Private Limited (Additional Director, 02 May 2020 to 15 May 2020); Auro Peptides Limited (Director, 02 Jan 2012 to 02 Nov 2021); Curepro Parenterals Limited (Director, 19 Apr 2013 to 22 Aug 2013); Pharmaceuticals Export Promotion Council Of India (Director, 13 Apr 2004 to 09 Jan 2017); Auronext Pharma Private Limited (Director, 30 Jul 2010 to 31 Aug 2020); and 6 more.
The current boards of Nityananda Reddy Kambam's companies include Adi Reddy Baddigam (Aurobindo Pharma Ltd), Girish Paman Vanvari (Aurobindo Pharma Ltd), Madan Mohan Reddy Mettu (Aurobindo Pharma Ltd), Mangalam Ramasubramanian Kumar (Aurobindo Pharma Ltd), Punita Kumar Sinha (Aurobindo Pharma Ltd), Santanu Mukherjee (Aurobindo Pharma Ltd), among others.